Carlisle (CSL) PT Raised to $180 at Oppenheimer
Tweet
Share
E-mailGet Alerts CSL Hot Sheet
Price: $365.63 +2.96%
Rating Summary:
10 Buy, 12 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Rating Summary:
10 Buy, 12 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Join SI Premium – FREE
Oppenheimer analyst Bryan Blair raised the price target on Carlisle (NYSE: CSL) to $180.00 (from $177.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Moderna (MRNA) PT Raised to $89 at Morgan Stanley
- Keysight Technologies (KEYS) PT Raised to $440 at UBS Amid Broad-Based AI Strength
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
